Company / Current Liabilities per Share
Perspective Therapeutics, Inc. Current Liabilities per Share History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.02
FY2022
5-year range
$0.02 / $0.03
FY2018-FY2022
Trend
-15.9%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.02 in FY2019 to $0.03 in FY2018.
Based on SEC 10-K filings.
0.02 in FY2022 with a 5-year CAGR of +1.8%.
Improved from $0.02 to $0.02 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +3.4%
- 5-Year CAGR
- +1.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, current liabilities per share decreased 15.9% year-over-year.
- Peak current liabilities per share was recorded in FY2018.
- Lowest current liabilities per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.02 | -15.9% |
| FY2021 | $0.03 | +11.8% |
| FY2020 | $0.02 | +17.4% |
| FY2019 | $0.02 | -40.3% |
| FY2018 | $0.03 | +65.9% |
| FY2017 | $0.02 | -23.6% |
| FY2016 | $0.03 | +0.1% |
| FY2015 | $0.03 | -21.1% |
| FY2014 | $0.03 | +30.1% |
| FY2013 | $0.03 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026